Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

(NASDAQ:ACET) REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference being held from September 8-10, 2025 in New York. Details of the event are as follows: Date: Monday, September 8, 2025 Time: 4: